88 research outputs found

    Antibiotic use and resistance : patterns, perceptions, policy and the price to pay

    No full text
    Background: Antibiotic resistance is a major health challenge especially in low and middle income countries such as India. Inappropriate antibiotic use is one important factor contributing to resistance. Strategies to improve use would help contain resistance. In order to develop strategies that are feasible and appropriate, knowledge is needed about patterns and perceptions of antibiotic use, the consequences of resistance and impact of policy guidelines. Current knowledge and evidence is limited in India.Aim: To improve knowledge on the patterns and perceptions of antibiotic use in the community, the consequences of resistance in individual patients, and the impact of policy guidelines on hospital antibiotic use, so as to identify potential interventional targets, generate key messages and subsequently develop appropriate strategies towards improving use and containing resistance. The specific objectives were:1. To determine patterns of antibiotic use through a surveillance system in the community and challenges faced while developing the system. (I)2. To ascertain the perceptions of stakeholders in antibiotic use and resistance and highlight the challenges to changing practice. (II)3. To assess the impact of antibiotic resistance on cost burden and health consequences in patients with suspected sepsis. (III)4. To determine patterns of inpatient antibiotic use over a decade and evaluate the impact of policy guidelines and modes of dissemination on antibiotic use. (IV)Methods: The first two studies (Paper I & II) for this thesis were done in urban and rural areas of Vellore district, south India and the two other studies (Paper III & IV) at Christian Medical College, Vellore (CMC), a not for profit, university teaching hospital with 2140 beds. Surveillance of antibiotic use patterns (prescriptions and dispensations) in thirty community healthcare facilities for 2 years was conducted with a repeated cross-sectional design (I). A qualitative study with eight focus group discussions among doctors, pharmacists and public explored perceptions about resistance, antibiotic use practices, factors driving use, and strategies for appropriate use (II). A one year observational study on inpatients with a preliminary diagnosis of suspected sepsis and a positive blood culture report analysed costs and health consequences in two groups, ‘resistant’ and ‘susceptible’ based on susceptibility of causative bacteria to the empiric antibiotic given (III). A time series segmented regression analysis of antibiotic use across a decade revealed the patterns of use over time segments and the impact of differing modes of policy guideline development and implementation (IV).Findings: Surveillance in community healthcare facilities (I) revealed that among 52,788 patients, 40.9% were prescribed or dispensed antibiotics (antibiotic encounters). There were significant differences among facilities types and areas. Fluoroquinolones and penicillins were widely used, co-trimoxazole more in rural hospitals and cephalosporins in urban private hospitals. 41.1% of antibiotics were for respiratory infections. Focus group discussions (II) revealed that the public had limited awareness of infection, antibiotics and resistance and wanted quick relief through antibiotics. Doctors prescribed antibiotics for perceived patient expectations and quick recovery. Business concerns promoted antibiotic sales by pharmacists. Improving public awareness, provider communication, diagnostic support, and strict regulatory implementation were suggested strategies. Among 220 patients admitted into the hospital with suspected sepsis (III), the median difference between ‘resistant’ and ‘susceptible’ groups in overall costs, antibiotic costs and pharmacy costs was Rs. 41,993 (p = 0.001), 8,315 (p Conclusion: The level of antibiotic use is significant in the community, especially for respiratory infections and fluoroquinolone use. Patterns of antibiotic use varied among healthcare facilities and stakeholders. Knowledge and understanding of resistance was limited. Patient demand and competitive pressures were some of the main challenges expressed in changing practice. Antibiotic resistance had significant impact on cost and health consequences in patients. Containment of rising inpatient antibiotic use was possible with guideline dissemination through intranet computer network.List of scientific papersI. Chandy SJ, Thomas K, Mathai E, Antonisamy B, Holloway KA, Stalsby Lundborg C. Patterns of antibiotic use in the community and challenges of antibiotic surveillance in a lower-middle-income country setting: a repeated cross-sectional study in Vellore, south India. J Antimicrob Chemother. 2013 Jan;68(1):229-36. https://doi.org/10.1093/jac/dks355 II. Chandy SJ, Mathai E, Thomas K, Faruqui AR, Holloway K, Stalsby Lundborg C. Antibiotic Use and Resistance: perceptions and ethical challenges among doctors, pharmacists and the public in Vellore, South India. Indian J Medical Ethics. 2013 Jan-Mar;10(1):20-27. https://pubmed.ncbi.nlm.nih.gov/23439193III. Chandy SJ, Naik GS, Balaji V, Jeyaseelan V, Thomas K, Stalsby Lundborg C. High Cost Burden and Health Consequences of Antibiotic Resistance – The Price to Pay. [Submitted]IV. Chandy SJ, Naik GS, Charles R, Jeyaseelan V, Naumova EN, Thomas K, Stalsby Lundborg C. The Impact of Policy Guidelines on Hospital Antibiotic Use over a Decade: A Segmented Time Series Analysis. PLoS One. 2014 Mar 19;9(3):e92206. https://doi.org/10.1371/journal.pone.0092206 </p

    Consequences of irrational use of antibiotics

    No full text

    An Examination of the Globalisation of Authorship in Publishing in 20 Leading Marketing Journals

    No full text
    Purpose of this paper is to examine the global contribution of academics to marketing literature between 1999 and 2003, based on an examination of the location of academics institution of employment, as reported in published works. The data is used to evaluate the global dispersion of publishing.\ud Design/approach. The paper uses the method of content analysis where the authorship of all articles in 20 leading marketing journals between 1999 and 2003 is examined. An empirical examination of performance was undertaken across geographic regions. There was also an examination of whether the quality of journal affected regional performance.\ud Findings. The research found that there is a significant "bias" of authorship within the 20 journals examined, with the majority of works published by academics at institutions in North America. There is some variation in regional performance based on the type of journal examined. Limitations. There was no attempt to empirically examine why differences might exist. The study only focused on a sample of 20 English language journals over 5 years. These journals have been included in studies that list the leading marketing journal for US and European academics. Practical Implications. The research suggests that there may in fact be regional differences in publishing behaviour. It is unclear if these differences relate to variations in the "objectives" of institutions within each country or other factors, such as the North American publish-or-perish mentality. The research posits that a marketing knowledge may be unnecessarily restricted, if there is a bias against non-North American perspectives. Originality. While there have been other works examining research performance of institutions, there has been limited examination in marketing on the nation in which authors work and none have used a broad cross-section of journals. This work takes a global "snapshot" of national research performance within marketing

    A One Health Review of Community-Acquired Antimicrobial-Resistant Escherichia coli in India

    No full text
    Antimicrobial resistance (AMR) threatens to undermine nearly a century of progress since the first use of antimicrobial compounds. There is an increasing recognition of the links between antimicrobial use and AMR in humans, animals, and the environment (i.e., One Health) and the spread of AMR between these domains and around the globe. This systematic review applies a One Health approach-including humans, animals, and the environment-to characterize AMR in Escherichia coli in India. E. coli is an ideal species because it is readily shared between humans and animals, its transmission can be tracked more easily than anaerobes, it can survive and grow outside of the host environment, and it can mobilize AMR genes more easily than other intestinal bacteria. This review synthesized evidence from 38 studies examining antimicrobial-resistant E. coli (AR-E) across India. Studies of AR-E came from 18 states, isolated from different sample sources: Humans (n = 7), animals (n = 7), the environment (n = 20), and combinations of these categories, defined as interdisciplinary (n = 4). Several studies measured the prevalence of AMR in relation to last-line antimicrobials, including carbapenems (n = 11), third-generation cephalosporins (n = 18), and colistin (n = 4). Most studies included only one dimension of the One Health framework, highlighting the need for more studies that aim to characterize the relationship of AMR across different reservoirs of E. coli

    Are all new drugs ‘healthy’?

    No full text

    Medico Friend Circle Bulletin, 316-317, April-June 2006

    No full text
    Contents: Impressions from a Rural Laboratory - Jan Swasthya Sahyog Surgical Care for Rural India – A Perspective - George Mathew Excessive Use of Screening and Diagnostic Tests - Anant Phadke Are Glass Syringes Inferior? - Jan Swasthya Sahyog, Bilaspur The Quality and Cost of Health Care: Some Notes on the Context - Binayak Sen Quality and Costs of Health Care in the Context of the Goal of Universal Access - Sara Bhattacharji Cost Containment in Trauma Care Services - Jacob John What can we learn from the AIDS Movement? - Anand Zachariah Quality of Medical Care: Public versus Private - Alpana Sagar Some Strategies to Cut Health Care Costs - Vinod Shah Medical Facilities and Health Needs on Wheels: Still Unviable? - Dr. N. Kannan Rational Drug Therapy: Principles, Realities and Road Ahead - Sujith J Chandy Quality of Care: The Ayurvedic Perspective - P. Ram Manohar Quality Assurance in the National Rural Health Mission (NRHM): Provisions and Debates - Rajib Dasgupta Financing the NRHM - Ravi Duggal Declaration of Women Healers and CHWs Terrorism, Pfizer Style - James Love Vadodara: The Context of the Dargah Demolitionpublic health, NRHM, quality of care, medical care, health care costs, medical facilities, ayurveda, rational drug therapy,healers, CHWs, Pfizer, Health Studies
    corecore